Bcl-2 expression is correlated with low apoptotic index and associated with histopathological grading in esophageal squamous cell carcinomas

被引:27
作者
Azmi, S
Dinda, AK
Chopra, P
Chattopadhyay, TK
Singh, N
机构
[1] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Surg, New Delhi 110029, India
关键词
apoptosis; Bcl-2; squamous cell carcinoma; p53;
D O I
10.1159/000030105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to examine the relationship between apoptosis, protein expression of apoptosis mediator and inhibitor genes p53 and bcl-2 and various histopathological grades of squamous cell carcinoma of the esophagus. Apoptotic index was evaluated in thirty human esophageal squamous cell carcinomas and adjoining normal tissue by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL). Protein expression of bcl-2 and p53 was measured by immunohistochemical staining of cryocut sections and Western blotting. Apoptototic cells were seen mainly around areas of keratinization and the apoptotic index was highest in well-differentiated squamous cell carcinomas. High Bcl-2 expression correlated inversely with the apoptotic index. p53 protein expression did not correlate with the grade of the tumor or the apoptotic index. We propose that deregulation of apoptosis contributes to the pathogenesis of esophageal squamous cell carcinoma. Copyright (C) 2000 S. Karger AG, asel.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 29 条
[1]   PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER [J].
BELL, SM ;
SCOTT, N ;
CROSS, D ;
SAGAR, P ;
LEWIS, FA ;
BLAIR, GE ;
TAYLOR, GR ;
DIXON, MF ;
QUIRKE, P .
GASTROENTEROLOGY, 1993, 104 (01) :57-64
[2]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[3]   APOPTOSIS AND EXPRESSION OF THE BCL-2 PROTOONCOGENE IN THE FETAL AND ADULT HUMAN KIDNEY - EVIDENCE FOR THE CONTRIBUTION OF BCL-2 EXPRESSION TO RENAL CARCINOGENESIS [J].
CHANDLER, D ;
ELNAGGAR, AK ;
BRISBAY, S ;
REDLINE, RW ;
MCDONNELL, TJ .
HUMAN PATHOLOGY, 1994, 25 (08) :789-796
[4]  
CHIENG DC, 1996, MODERN PATHOL, V9, P402
[5]  
Du MQ, 1996, J PATHOL, V178, P379
[6]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[7]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[8]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[9]  
Kiberu SW, 1996, J CLIN PATHOL-CL MOL, V49, pM268
[10]   THE P53 PROTEIN AND ITS INTERACTIONS WITH THE ONCOGENE PRODUCTS OF THE SMALL DNA TUMOR-VIRUSES [J].
LEVINE, AJ .
VIROLOGY, 1990, 177 (02) :419-426